Discussion about this post

User's avatar
Kat Fu, M.S., M.S.'s avatar

Really appreciate this, Dr. Ashori.

I’d add that day-to-day stool observation—color, texture, frequency—is often overlooked but can offer meaningful clues.

I do wonder if FOBT and even FIT might reflect a relatively late stage in the progression, since bleeding often suggests existing lesions.

That said, they’re still valuable tools—ideally complementing, not replacing, colonoscopy when appropriate.

In some cases, MR enterography can offer a less invasive but still detailed view, depending on the clinical picture.

Expand full comment
Dr. Ashori MD's avatar

Thank you for everyone's wonderful feedback on this article. Since this question came up a few times I thought I'd answer it here: no, I don't make any money from this product and don't know the manufacturer other than what's listed on the FDA website and my own experience. As a physician, I have access to many different colon cancer screening options for my patients and because my medical practice is a direct-pay model, I have no financial incentive in any medications I prescribe, labs or imaging studies I order, or any other profit model.

Expand full comment
2 more comments...

No posts